Elanco Animal Health Incorporated
NYSE:ELAN
14.47 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,184 | 1,205 | 1,035 | 1,068 | 1,057 | 1,257 | 988 | 1,028 | 1,177 | 1,225 | 1,113 | 1,131 | 1,279 | 1,242 | 1,139.7 | 889.6 | 586.3 | 657.7 | 787 | 771.3 | 781.6 | 731.1 | 799.3 | 761.1 | 770.2 | 736.2 | 754.3 | 697.1 | 718.8 | 718.8 |
| Cost of Revenue
| 626 | 515 | 516 | 487 | 434 | 494 | 448 | 472 | 484 | 509 | 512 | 502 | 551 | 569 | 596.2 | 441.8 | 295.9 | 332.7 | 410.1 | 360.4 | 356 | 343.8 | 412.5 | 369.8 | 431.5 | 360 | 405 | 376.2 | 343.1 | 343.1 |
| Gross Profit
| 558 | 690 | 519 | 581 | 623 | 763 | 540 | 556 | 693 | 716 | 601 | 629 | 728 | 673 | 543.5 | 447.8 | 290.4 | 325 | 376.9 | 410.9 | 425.6 | 387.3 | 386.8 | 391.3 | 338.7 | 376.2 | 349.3 | 320.9 | 375.7 | 375.7 |
| Gross Profit Ratio
| 0.471 | 0.573 | 0.501 | 0.544 | 0.589 | 0.607 | 0.547 | 0.541 | 0.589 | 0.584 | 0.54 | 0.556 | 0.569 | 0.542 | 0.477 | 0.503 | 0.495 | 0.494 | 0.479 | 0.533 | 0.545 | 0.53 | 0.484 | 0.514 | 0.44 | 0.511 | 0.463 | 0.46 | 0.523 | 0.523 |
| Reseach & Development Expenses
| 89 | 87 | 79 | 86 | 81 | 81 | 80 | 78 | 82 | 81 | 92 | 94 | 94 | 89 | 112.7 | 88.1 | 59.4 | 66.8 | 67.3 | 69.9 | 68.8 | 64.1 | 61.1 | 58.9 | 61.4 | 65.2 | 62 | 61.9 | 63.95 | 63.95 |
| General & Administrative Expenses
| 0 | 0 | 85 | 0 | 0 | 0 | 102 | 0 | 0 | 0 | 81 | 0 | 0 | 0 | 182 | 0 | 0 | 182 | 185.9 | 192.3 | 200.9 | 181.1 | 185.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 207 | 0 | 0 | 0 | 201 | 0 | 0 | 0 | 248 | 0 | 0 | 0 | 611 | 0 | 0 | 182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 354 | 337 | 292 | 313 | 353 | 327 | 303 | 298 | 343 | 320 | 329 | 342 | 385 | 348 | 374.1 | 277.7 | 162.8 | 182 | 185.9 | 192.3 | 200.9 | 181.1 | 185.1 | 179 | 191.1 | 180 | 196.8 | 194.7 | 194.2 | 194.2 |
| Other Expenses
| -2 | -9 | -34 | -9 | -23 | 134 | 130 | 128 | 133 | 137 | 3 | -11 | 3 | 147 | 16.6 | 114.9 | 47.9 | -1.1 | -6.3 | -14.6 | -3.9 | -2.6 | -25.7 | -13.5 | -8.8 | -1.9 | 0 | 1.9 | 0 | 0 |
| Operating Expenses
| 443 | 557 | 509 | 539 | 570 | 542 | 513 | 504 | 558 | 538 | 560 | 577 | 608 | 584 | 650.5 | 461.4 | 271.2 | 300.4 | 304.6 | 312.9 | 319 | 294.2 | 296.3 | 286.6 | 301.9 | 294.4 | 319 | 308.2 | 409.7 | 409.7 |
| Operating Income
| 115 | 133 | -24 | 42 | 53 | 212 | 6 | 44 | 135 | 169 | -66 | 52 | 120 | 89 | -107 | -13.6 | 19.2 | 24.6 | 72.3 | 98 | 106.6 | 93.1 | 90.5 | 104.7 | 36.8 | 81.8 | 30.3 | 12.7 | 62.85 | 62.85 |
| Operating Income Ratio
| 0.097 | 0.11 | -0.023 | 0.039 | 0.05 | 0.169 | 0.006 | 0.043 | 0.115 | 0.138 | -0.059 | 0.046 | 0.094 | 0.072 | -0.094 | -0.015 | 0.033 | 0.037 | 0.092 | 0.127 | 0.136 | 0.127 | 0.113 | 0.138 | 0.048 | 0.111 | 0.04 | 0.018 | 0.087 | 0.087 |
| Total Other Income Expenses Net
| -147 | -55 | -70 | -1,067 | -58 | -104 | -94 | -86 | -153 | -98 | -107 | -122 | -296 | -108 | -150.7 | -147.3 | -71.5 | -75.9 | -57.9 | -91.8 | -35.7 | -27.5 | -71.7 | -25.9 | -76.8 | -4.3 | -185.7 | -21.8 | -96.85 | -96.85 |
| Income Before Tax
| -32 | 12 | -127 | -1,097 | -79 | 108 | -88 | -42 | -18 | 71 | -121 | -130 | -236 | -80 | -318.1 | -209 | -77.1 | -67.8 | -4.3 | -12.5 | 50.2 | 44.8 | -2.2 | 78.8 | -40 | 77.5 | -155.4 | -9.1 | -34 | -34 |
| Income Before Tax Ratio
| -0.027 | 0.01 | -0.123 | -1.027 | -0.075 | 0.086 | -0.089 | -0.041 | -0.015 | 0.058 | -0.109 | -0.115 | -0.185 | -0.064 | -0.279 | -0.235 | -0.132 | -0.103 | -0.005 | -0.016 | 0.064 | 0.061 | -0.003 | 0.104 | -0.052 | 0.105 | -0.206 | -0.013 | -0.047 | -0.047 |
| Income Tax Expense
| 18 | -20 | 14 | -1 | 18 | 5 | -34 | 7 | 4 | 23 | -24 | -26 | -26 | -19 | 4.7 | -74 | -23.9 | -18.7 | 5.2 | -22.5 | 14.3 | 13.3 | -18.6 | 18.6 | 22.8 | 4.8 | 6.1 | 11.6 | 30.25 | 30.25 |
| Net Income
| -50 | 32 | -141 | -1,096 | -97 | 103 | -54 | -49 | -22 | 51 | -97 | -104 | -210 | -61 | -322.8 | -135 | -53.2 | -49.1 | -9.5 | 10 | 35.9 | 31.5 | 16.4 | 60.2 | -62.8 | 72.7 | -161.5 | -20.7 | -64.25 | -64.25 |
| Net Income Ratio
| -0.042 | 0.027 | -0.136 | -1.026 | -0.092 | 0.082 | -0.055 | -0.048 | -0.019 | 0.042 | -0.087 | -0.092 | -0.164 | -0.049 | -0.283 | -0.152 | -0.091 | -0.075 | -0.012 | 0.013 | 0.046 | 0.043 | 0.021 | 0.079 | -0.082 | 0.099 | -0.214 | -0.03 | -0.089 | -0.089 |
| EPS
| -0.1 | 0.06 | -0.29 | -2.22 | -0.2 | 0.21 | -0.11 | -0.1 | -0.045 | 0.1 | -0.2 | -0.21 | -0.43 | -0.13 | -0.66 | -0.29 | -0.13 | -0.12 | -0.026 | 0.03 | 0.1 | 0.09 | 0.04 | 0.16 | -0.18 | 0.2 | -0.45 | -0.057 | 0 | 0 |
| EPS Diluted
| -0.1 | 0.06 | -0.29 | -2.22 | -0.2 | 0.21 | -0.11 | -0.1 | -0.045 | 0.1 | -0.2 | -0.21 | -0.43 | -0.13 | -0.66 | -0.29 | -0.13 | -0.12 | -0.025 | 0.03 | 0.1 | 0.09 | 0.04 | 0.16 | -0.18 | 0.2 | -0.44 | -0.057 | 0 | 0 |
| EBITDA
| 277 | 290 | 147 | 173 | 166 | 346 | 136 | 211 | 268 | 345 | 183 | 182 | 293 | 291 | 73.3 | 233.6 | 148 | 105 | 117.4 | 134.1 | 152 | 139.5 | 186.6 | 165.8 | 103.3 | 154.2 | 303.2 | 111.6 | 140.9 | 140.9 |
| EBITDA Ratio
| 0.234 | 0.241 | 0.142 | 0.162 | 0.157 | 0.275 | 0.138 | 0.205 | 0.228 | 0.282 | 0.164 | 0.161 | 0.229 | 0.234 | 0.064 | 0.263 | 0.252 | 0.16 | 0.149 | 0.174 | 0.194 | 0.191 | 0.233 | 0.218 | 0.134 | 0.209 | 0.402 | 0.16 | 0.196 | 0.196 |